ARWR vs. QQQ
Compare and contrast key facts about Arrowhead Pharmaceuticals, Inc. (ARWR) and Invesco QQQ (QQQ).
QQQ is a passively managed fund by Invesco that tracks the performance of the NASDAQ-100 Index. It was launched on Mar 10, 1999.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ARWR or QQQ.
Key characteristics
| ARWR | QQQ | |
|---|---|---|
| YTD Return | -24.28% | 3.07% |
| 1Y Return | -34.51% | 32.86% |
| 3Y Return (Ann) | -31.82% | 8.34% |
| 5Y Return (Ann) | 5.04% | 17.98% |
| 10Y Return (Ann) | 7.74% | 18.03% |
| Sharpe Ratio | -0.57 | 1.95 |
| Daily Std Dev | 62.03% | 16.25% |
| Max Drawdown | -99.96% | -82.98% |
| Current Drawdown | -99.21% | -5.57% |
Correlation
The correlation between ARWR and QQQ is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ARWR vs. QQQ - Performance Comparison
In the year-to-date period, ARWR achieves a -24.28% return, which is significantly lower than QQQ's 3.07% return. Over the past 10 years, ARWR has underperformed QQQ with an annualized return of 7.74%, while QQQ has yielded a comparatively higher 18.03% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ARWR vs. QQQ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Arrowhead Pharmaceuticals, Inc. (ARWR) and Invesco QQQ (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ARWR vs. QQQ - Dividend Comparison
ARWR has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.63%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARWR Arrowhead Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QQQ Invesco QQQ | 0.63% | 0.62% | 0.80% | 0.43% | 0.55% | 0.74% | 0.91% | 0.84% | 1.06% | 0.99% | 1.41% | 1.01% |
Drawdowns
ARWR vs. QQQ - Drawdown Comparison
The maximum ARWR drawdown since its inception was -99.96%, which is greater than QQQ's maximum drawdown of -82.98%. Use the drawdown chart below to compare losses from any high point for ARWR and QQQ. For additional features, visit the drawdowns tool.
Volatility
ARWR vs. QQQ - Volatility Comparison
Arrowhead Pharmaceuticals, Inc. (ARWR) has a higher volatility of 14.10% compared to Invesco QQQ (QQQ) at 5.42%. This indicates that ARWR's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.